solute carrier family 40 member 1
Last updated 28 Sept 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The SLC40A1 gene provides instructions for making a protein called ferroportin. This protein is involved in the process of absorbing iron that the body receives from food. Ferroportin transports iron obtained from the diet that is absorbed through the walls of the small intestine into the bloodstream. The iron is carried by the blood to the tissues and organs of the body. Ferroportin also transports iron out of specialized immune system cells (called reticuloendothelial cells) that are found in the liver, spleen, and bone marrow. The amount of iron absorbed during digestion depends on the amount of iron transported from intestinal and reticuloendothelial cells.
Video picks for GenesVideo library
Normal function
The SLC40A1 gene provides instructions for making a protein called ferroportin. This protein is involved in the process of absorbing iron that the body receives from food. Ferroportin transports iron obtained from the diet that is absorbed through the walls of the small intestine into the bloodstream. The iron is carried by the blood to the tissues and organs of the body. Ferroportin also transports iron out of specialized immune system cells (called reticuloendothelial cells) that are found in the liver, spleen, and bone marrow. The amount of iron absorbed during digestion depends on the amount of iron transported from intestinal and reticuloendothelial cells.
The amount of ferroportin available to transport iron is controlled by another iron regulatory protein, hepcidin. Hepcidin attaches (binds) to ferroportin and causes it to be broken down when the body's iron supplies are normal. When the body is low on iron, hepcidin levels decrease and more ferroportin is available to transport iron into the bloodstream so it can be delivered to tissues throughout the body.
Conditions referring to this gene or chromosome
Other names
Ferroportin 1
FPN1
HFE4
IREG1
Iron regulated gene 1
Iron-regulated transporter 1
MTP1
S40A1_HUMAN
SLC11A3
Solute carrier family 11 (proton-coupled divalent metal ion transporters), member 3
solute carrier family 40 (iron-regulated transporter), member 1
Patient picks for Genes

Sexual health
The truth about getting pregnant after 40
Is conceiving in your forties just a lottery, or are there key factors that can significantly lower or increase your chances of starting a family mid-life? We ask the experts.
by Sally Turner

Podcasts
The parental minefield
How often have you said something quite ordinary to a parent, or they’ve said something to you and suddenly the room feels like it’s about to explode? Welcome to the parental nightmare. It’s not just about conflict, it’s about what’s hidden underneath these relationships – family secrets, unspoken stories, patterns of behaviour passed from one generation to the next. In this episode Clare and Aileen explore the complex, often lifelong, relationship we have with our parents and discuss practical strategies to help you navigate this important relationship.
by Thomas Andrew Porteus, MBCS

Hormones
Do you need a menopause check at 40?
In the UK, the Menopause All-Party Parliamentary Group (APPG) has suggested seven reforms to UK menopause health policy that it recommends should be implemented by MPs. One of the key recommendations is that a standard menopause check should be integrated into the NHS free Health Check for all women over 40. Here we look at if this check is necessary, what it would it entail, and why the age of 40 has been chosen.
by Amberley Davis

Mental health
Not quite 'back to normal': a guide to post-pandemic family healing
When news broke in late 2019 of a virus spreading rapidly across the globe, the word ‘unprecedented’ quickly became part of everyday vocabulary in the months that followed. The outbreak of Covid-19 marked the world’s most significant public health crisis in at least a century, shaking the foundations of the one place we usually feel most secure - the home. It is no surprise that years of disrupted routines have left a lasting mark on the family unit. From the sudden loss of support networks to the blurring of boundaries between home, school, and work, the pandemic reshaped how families function. We spoke with a psychotherapist to explore these long-term psychological ripples and why reflecting on that period is essential for understanding - and healing - the family dynamic today.
by Victoria Raw

Children's health
Pearson syndrome: how one family learned to live in the present
Pearson syndrome is a rare and serious mitochondrial disorder that typically affects infants and young children. There is currently no cure, and it is usually life-threatening. We follow one family’s journey of living with the condition, exploring how it shapes their everyday lives, the challenges they face, and what it truly means to cherish every moment.
by Victoria Raw

COVID-19
COVID-19: how to support vulnerable friends and family during the coronavirus pandemic
Current coronavirus lockdown measures are especially challenging for older people and those with mental health issues and underlying health conditions. We look at how to support vulnerable loved ones during the COVID-19 pandemic.
by Sally Turner
Related patient information and medicines

Patient information leaflet
Cystic fibrosis
What causes cystic fibrosis. Cystic fibrosis is a genetic disorder. A genetic disorder is one that can be passed on from your parents through your genes. How is cystic fibrosis inherited. Cystic fibrosis is an autosomal recessive disorder. This means that in order to develop cystic fibrosis you need to inherit two cystic fibrosis genes, one from.

Patient information leaflet
Polycystic kidney disease
This means that one or more of your genes is faulty, which results in you making many cysts in the kidneys. There are different types of polycystic kidney disease: Autosomal dominant polycystic kidney disease (ADPKD) This is the most common type. This is an hereditary condition caused by a faulty gene which is inherited from one parent. Autosomal.

Patient information leaflet
Wilson's disease
Wilson's disease is a genetic disorder in which copper builds up in the body, mainly in the liver and brain. Without any treatment, the build-up of copper can cause serious symptoms. Treatment is with medication to remove the excess copper and/or to prevent a further build-up of copper. What is Wilson's disease. Wilson's disease is a condition.

Patient information leaflet
Breast cancer in men
The main gene which can cause men to be more at risk of breast cancer is the BRCA2 gene. If two or more of your close family have developed breast cancer, particularly if they had it under the age of 50, you may also be at risk of breast cancer. If a close family member developed breast cancer under the age of 40, a flawed gene might have been the.

Patient information leaflet
Haemochromatosis
Find out more here: [https://patient.info/health/haemochromatosis-leaflet](https://patient.info/health/haemochromatosis-leaflet) People with haemochromatosis have inherited a faulty gene, which directs the body to absorb too much iron from what they eat and drink. Causes of haemochromatosis Haemochromatosis is a genetic condition. Approximately 1.

Patient information leaflet
Hereditary spherocytosis
Hereditary spherocytosis (HS) is an inherited condition of red blood cells. The disease can be mild and go unrecognised in some people. In others there may be severe anaemia requiring regular blood transfusions. Some people with hereditary spherocytosis may be offered surgery to remove their spleen. This usually helps the condition, but increases.
Further reading and references
- solute carrier family 40 member 1; MedlinePlus, National Library of Medicine.
- De Domenico I, Ward DM, Musci G, Kaplan J. Iron overload due to mutations in ferroportin. Haematologica. 2006 Jan;91(1):92-5.
- De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, Kaplan J. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):8955-60. doi: 10.1073/pnas.0503804102. Epub 2005 Jun 13.
- Devalia V, Carter K, Walker AP, Perkins SJ, Worwood M, May A, Dooley JS. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood. 2002 Jul 15;100(2):695-7. doi: 10.1182/blood-2001-11-0132.
- Gerhard GS, Paynton BV, DiStefano JK. Identification of Genes for Hereditary Hemochromatosis. Methods Mol Biol. 2018;1706:353-365. doi: 10.1007/978-1-4939-7471-9_19.
- Majore S, Bonaccorsi di Patti MC, Valiante M, Polticelli F, Cortese A, Di Bartolomeo S, De Bernardo C, De Muro M, Faienza F, Radio FC, Grammatico P, Musci G. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis. Biochim Biophys Acta Mol Basis Dis. 2018 Feb;1864(2):464-470. doi: 10.1016/j.bbadis.2017.11.006. Epub 2017 Nov 14.
- McKie AT, Barlow DJ. The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1). Pflugers Arch. 2004 Feb;447(5):801-6. doi: 10.1007/s00424-003-1102-3. Epub 2003 Jun 27.
- McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000 Feb;5(2):299-309. doi: 10.1016/s1097-2765(00)80425-6.
- Pietrangelo A. Ferroportin disease: pathogenesis, diagnosis and treatment. Haematologica. 2017 Dec;102(12):1972-1984. doi: 10.3324/haematol.2017.170720. Epub 2017 Nov 3.
- Rivers CA, Barton JC, Gordeuk VR, Acton RT, Speechley MR, Snively BM, Leiendecker-Foster C, Press RD, Adams PC, McLaren GD, Dawkins FW, McLaren CE, Reboussin DM. Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol Dis. 2007 May-Jun;38(3):247-52. doi: 10.1016/j.bcmd.2006.12.002. Epub 2007 Feb 5.
- Thomas C, Oates PS. Ferroportin/IREG-1/MTP-1/SLC40A1 modulates the uptake of iron at the apical membrane of enterocytes. Gut. 2004 Jan;53(1):44-9. doi: 10.1136/gut.53.1.44.
- Wallace DF, Pedersen P, Dixon JL, Stephenson P, Searle JW, Powell LW, Subramaniam VN. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood. 2002 Jul 15;100(2):692-4. doi: 10.1182/blood.v100.2.692.
- Zhang W, Lv T, Huang J, Ou X. Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: A case report and a review of the literature. Medicine (Baltimore). 2017 Sep;96(38):e8064. doi: 10.1097/MD.0000000000008064.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

